The increasing use of GLP-1 receptor agonists for weight loss and metabolic improvements has led to the recognition of various side effects. One potential, yet underexplored, adverse effect is hair loss. This study aims to investigate the frequency, characteristics, and predictors of hair loss in patients using GLP-1RAs.
Keywords: GLP‐1 receptor agonists, Mounjaro, clinical management, gender differences, hair loss, semaglutide, side effects, telogen effluvium, tirzepatide, weight loss
Journal of cosmetic dermatology
Journal Article
English
41914454
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.